Middleton & CO Inc Merck & Co., Inc. Transaction History

Middleton & CO Inc

$898 Million
Q3 2024

A detailed history of Middleton & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Middleton & CO Inc holds 138,162 shares of MRK stock, worth $14 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

138,162

Previous 135,828 1.72%

Holding current value

$14 Million

Previous $16.8 Million 6.7%

% of portfolio

1.75%

Previous 1.96%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$111.15 - $128.97 $259,424 - $301,015	2,334 Added 1.72%	138,162 $15.7 Million
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $318,537 - $342,106	-2,573 Reduced 1.86%	135,828 $16.8 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $43,484 - $50,668	384 Added 0.28%	138,401 $18.3 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $401,922 - $437,388	4,012 Added 2.99%	138,017 $15 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $6,177 - $6,859	-60 Reduced 0.04%	134,005 $13.8 Million
Q2 2023 Jul 28, 2023	SELL	$108.61 - $118.38 $4,453 - $4,853	-41 Reduced 0.03%	134,065 $15.5 Million
Q1 2023 Apr 28, 2023	SELL	$102.94 - $114.86 $65,881 - $73,510	-640 Reduced 0.47%	134,106 $14.3 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $101,517 - $130,159	-1,161 Reduced 0.85%	134,746 $14.9 Million
Q3 2022 Nov 02, 2022	SELL	$84.53 - $94.96 $1.02 Million - $1.14 Million	-12,021 Reduced 8.13%	135,907 $11.7 Million
Q2 2022 Jul 21, 2022	SELL	$83.49 - $94.64 $244,959 - $277,673	-2,934 Reduced 1.94%	147,928 $13.5 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $77,553 - $86,932	-1,055 Reduced 0.69%	150,862 $12.4 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $62,160 - $77,864	860 Added 0.57%	151,917 $11.6 Million
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $30,607 - $33,660	427 Added 0.28%	151,057 $11.3 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $265,842 - $294,048	-3,781 Reduced 2.45%	150,630 $11.7 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $19,211 - $22,629	-279 Reduced 0.18%	154,896 $11.5 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $33,397 - $39,338	-485 Reduced 0.31%	154,411 $11.9 Million
Q4 2020 Jan 29, 2021	SELL	$71.77 - $79.65 $46,291 - $51,374	-645 Reduced 0.41%	155,175 $12.7 Million
Q3 2020 Oct 30, 2020	BUY	$73.18 - $82.95 $89,499 - $101,447	1,223 Added 0.79%	155,820 $12.9 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $30,491 - $34,696	-433 Reduced 0.28%	154,597 $12 Million
Q1 2020 Apr 22, 2020	BUY	$63.36 - $87.82 $59,748 - $82,814	943 Added 0.61%	155,030 $11.9 Million
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $212,879 - $240,209	2,744 Added 1.81%	154,087 $14 Million
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $693,317 - $755,741	-9,113 Reduced 5.68%	151,343 $12.7 Million
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $345,288 - $403,380	-4,944 Reduced 2.99%	160,456 $13.5 Million
Q1 2019 Apr 25, 2019	SELL	$69.58 - $79.36 $420,611 - $479,731	-6,045 Reduced 3.53%	165,400 $13.8 Million
Q4 2018 Feb 01, 2019	BUY	$65.24 - $75.71 $575,743 - $668,140	8,825 Added 5.43%	171,445 $13.1 Million
Q3 2018 Oct 25, 2018	SELL	$57.69 - $67.84 $152,705 - $179,572	-2,647 Reduced 1.6%	162,620 $11.5 Million
Q2 2018 Jul 26, 2018	BUY	$50.83 - $59.72 $404,606 - $475,371	7,960 Added 5.06%	165,267 $10 Million
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $308,970 - $359,111	6,063 Added 4.01%	157,307 $8.57 Million
Q4 2017 Jan 25, 2018	SELL	$51.62 - $61.64 $397,525 - $474,689	-7,701 Reduced 4.85%	151,244 $8.51 Million
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $9.33 Million - $10 Million	158,945	158,945 $10.2 Million

Others Institutions Holding MRK

# of Institutions

3,802

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.

Account